$IVR Cashflow Statement | Understand Stock

$IVR

$5.52 -$0.01 (0.18%) Close

$IVR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows from Operating Activities
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Amortization of premiums and (discounts), net
Realized and unrealized (gain) loss on derivative instruments, net
Realized and unrealized (gain) loss on credit derivatives, net
(Gain) loss on investments, net
Allowance for credit losses
Increase (decrease) in provision for credit losses
(Gain) loss from investments in unconsolidated ventures in excess of distributions received
Other amortization
Net (gain) loss on extinguishment of debt
Loss on foreign currency translation
Changes in operating assets and liabilities:
(Increase) decrease in operating assets
Increase (decrease) in operating liabilities

Net cash provided by (used in) operating activities
Cash Flows from Investing Activities
Purchase of mortgage-backed securities
Purchase of U.S. Treasury securities
Distributions from investments in unconsolidated ventures, net
Change in other assets
Principal payments from mortgage-backed securities
Proceeds from sale of mortgage-backed securities
Payment on the sale of credit derivatives
Redemption of Federal Home Loan Bank of Indianapolis stock
Proceeds from sale of U.S. Treasury securities
Settlement (termination) of swaps, TBAs, futures and forwards, net
Net change in due from counterparties and collateral held payable on derivative instruments
Principal payments from commercial loan held-for-investment
Net cash provided by (used in) investing activities

Cash Flows from Financing Activities
Proceeds from issuance of common stock
Redemption of preferred stock
Repurchase of preferred stock
Cash paid in lieu of fractional shares in connection with one-for-ten reverse stock split
Principal repayments of secured loans
Proceeds from repurchase agreements
Principal repayments of repurchase agreements
Net change in due from counterparties and collateral held payable on repurchase agreements
Payments of deferred costs
Payments of dividends
Net cash provided by (used in) financing activities

Net change in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Supplement Disclosure of Cash Flow Information
Interest paid
Non-cash Investing and Financing Activities Information
Net change in unrealized gain (loss) on mortgage-backed securities classified as available-for-sale
Dividends declared not paid
Increase (decrease) in Agency CMBS purchase commitments
Net change in investment related receivable (payable)
Dividend paid in common stock
Net change in foreign currency translation adjustment recorded in accumulated other comprehensive income
Offering costs not paid
Unsettled receivables recorded within investment related receivable

Additional increases to the allowance for credit losses on securities that had an allowance recorded in a previous period
Increase (decrease) in provision for credit losses
(Gain) loss from investments in unconsolidated ventures in excess of distributions received

Comments